SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells
暂无分享,去创建一个
Gregory P Cosgrove | G. Cosgrove | C. Funk | K. Holmes | R. Mason | E. Mossel | Jieru Wang | Shuanglin Wang | R. Manzer | Kathryn V Holmes | Eric C Mossel | Robert J Mason | Jieru Wang | Scott Jeffers | Karen E Edeen | Shuanglin Wang | C Joel Funk | Rizwan Manzer | Tanya A Miura | Leonard D Pearson | Tanya A. Miura | K. Edeen | L. D. Pearson | S. Jeffers
[1] S. Asa,et al. Pulmonary pathology of severe acute respiratory syndrome in Toronto , 2005, Modern Pathology.
[2] M. McNutt,et al. Molecular Pathology in the Lungs of Severe Acute Respiratory Syndrome Patients , 2007, The American Journal of Pathology.
[3] R. Mason. Biology of alveolar type II cells , 2006, Respirology.
[4] C. Schwegmann-Wessels,et al. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. , 2006, The Journal of general virology.
[5] N. Pedemonte,et al. Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[6] K. Subbarao,et al. Is there an ideal animal model for SARS? , 2006, Trends in Microbiology.
[7] J. Crapo,et al. Allometric relationships of cell numbers and size in the mammalian lung. , 1992, American journal of respiratory cell and molecular biology.
[8] S. Perlman,et al. ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia , 2005, Journal of Virology.
[9] Junya Fukuoka,et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.
[10] Jill Taylor,et al. Discovery of Novel Human and Animal Cells Infected by the Severe Acute Respiratory Syndrome Coronavirus by Replication-Specific Multiplex Reverse Transcription-PCR , 2004, Journal of Clinical Microbiology.
[11] J. Druce,et al. SARS–associated Coronavirus Replication in Cell Lines , 2006, Emerging infectious diseases.
[12] J. Peiris,et al. Academic Editor: Sherif Zaki, Centers for Disease Control, United States of America , 2005 .
[13] N. Pedemonte,et al. Erratum: Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells (American Journal of Physiology - Lung Cellular and Molecular Physiology (February 2006) 290, 34, (L242-L249)) , 2006 .
[14] K. Brown,et al. TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. , 2006, American journal of respiratory cell and molecular biology.
[15] A. Danchin,et al. The Severe Acute Respiratory Syndrome , 2003 .
[16] R. Wiener,et al. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung , 2007, Journal of cellular biochemistry.
[17] R. Blumenthal,et al. Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection , 2005, Journal of Virology.
[18] Barry H. Smith,et al. A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.
[19] Y. Guan,et al. Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.
[20] Krishna Shankara Narayanan,et al. Exogenous ACE2 Expression Allows Refractory Cell Lines To Support Severe Acute Respiratory Syndrome Coronavirus Replication , 2005, Journal of Virology.
[21] C. Peters,et al. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) , 2004, Virology.
[22] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[23] Z. Li,et al. Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS† , 2006, The Journal of pathology.
[24] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[25] J. Crapo,et al. Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. , 1992, The American review of respiratory disease.
[26] Q. Xie,et al. RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro , 2004 .
[27] Q. Xie,et al. TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. , 2004, Life sciences.
[28] T. Ganz. Antimicrobial polypeptides in host defense of the respiratory tract. , 2002, The Journal of clinical investigation.
[29] Michelle M. Packard,et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan , 2005, Human Pathology.
[30] A. Nicholson,et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.
[31] Yongsheng Chang,et al. Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro. , 2007, American journal of respiratory cell and molecular biology.
[32] Z. Lang,et al. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS) , 2003, Pathology.
[33] K. Brown,et al. TNF-α Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-Induced Apoptosis , 2006 .
[34] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[35] Ralph S. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs , 2005, Journal of Virology.
[36] S. Harrison,et al. SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells , 2006, Journal of Biological Chemistry.
[37] Jinhua Lu,et al. The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages , 2007, Immunobiology.
[38] Qingling Zhang,et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.
[39] Tsai-Jung Wu,et al. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] Yi Guan,et al. Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.
[41] Bo Zhang,et al. Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.
[42] M. Hynes. Clinical Pathology , 1923 .
[43] Lucy A. Perrone,et al. Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial Cells , 2005, Journal of Virology.
[44] G. Tse,et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.